# Bristol-Myers Squibb Company (BMY) — Q3-2015 Earnings Results

**Report date:** 2015-10-27 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2015

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 3.49%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.39 | N/A | +10.80% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their product pipeline and future growth potential. However, they did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> Management highlighted the strong performance in their key therapeutic areas.

> They emphasized ongoing investment in research and development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 3.49% increase. The management's focus on their therapeutic areas and R&D investments suggests they are positioning for future growth, even without specific guidance. Investors may view this as a sign of stability and potential in the company's operations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2015_